Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial

<p>Introduction: We previously reported evidence that the T allele of the dopamine type-2 receptor (DRD2)rs1800497 polymorphism is associated with improved response to nicotine replacement therapy (NRT) relative to placebo and that this association may only be present in females. However, evid...

Descrizione completa

Dettagli Bibliografici
Autori principali: Munafo, M, Johnstone, E, Murphy, M, Aveyard, P
Altri autori: Society for Research on Nicotine and Tobacco (SRNT)
Natura: Journal article
Lingua:English
Pubblicazione: Oxford University Press 2009
Soggetti: